Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Conor Kleweno

Orthopaedic Trauma Seattle, WA Medical Doctor

NPI 1760687347 CMS profile 812068

325 9Th Ave, Seattle, WA 98104

Open in the dashboard

General payments

$695,126

485 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Conor Kleweno of Seattle, WA is reported in the CMS Open Payments database as having received $695,126 across 485 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Orthopaedic Trauma profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $186,565 50
2024 General $122,035 102
2023 General $113,908 115
2022 General $86,115 87
2021 General $76,354 58
2020 General $48,090 13
2019 General $62,059 60

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Conor Kleweno
  • Orthopaedic Trauma median
  • Middle half of Orthopaedic Trauma
  • National median

In program year 2025, general payments to Conor Kleweno were reported at $186,565. Among 734 Orthopaedic Trauma profiles paid that year, the median was $1,227 and the middle half received between $259 and $7,433.

Show as a table
Year Conor Kleweno Orthopaedic Trauma median Middle half National median
2019 $62,059 $1,475 $264–$6,401 $163
2020 $48,090 $596 $120–$4,020 $114
2021 $76,354 $919 $171–$4,697 $132
2022 $86,115 $1,547 $272–$7,240 $149
2023 $113,908 $1,330 $247–$5,875 $160
2024 $122,035 $1,288 $277–$6,797 $164
2025 $186,565 $1,227 $259–$7,433 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $471,579 306 payments
  2. SI-BONE, Inc. $102,701 82 payments
  3. Medical Device Business Services, Inc. $57,391 25 payments
  4. Synthes GmbH $36,061 41 payments
  5. Globus Medical, Inc. $25,314 18 payments
  6. Summit Surgical Corp. $1,218 2 payments
  7. NuVasive Specialized Orthopedics, Inc. $345 2 payments
  8. IlluminOss Medical, Inc. $171 1 payment
  9. DePuy Synthes Sales Inc. $169 6 payments
  10. Zimmer Biomet Holdings, Inc. $116 1 payment
  11. Other $62 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $430,325 118 payments
  2. Royalty or License $157,584 26 payments
  3. Travel and Lodging $72,207 181 payments
  4. Compensation for serving as faculty or as a speaker for a medical education program $18,250 9 payments
  5. Food and Beverage $9,560 146 payments
  6. Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program $6,000 4 payments
  7. Education $1,200 1 payment
Products named General payments · program years 2019–2025
  1. AXSOS $152,681 46 payments
  2. PANGEA $132,019 11 payments
  3. GAMMA $105,445 36 payments
  4. PRO $87,193 84 payments
  5. HOFFMANN $75,005 13 payments
  6. T2 $68,481 29 payments
  7. VARIAX $63,620 38 payments
  8. LOW PROFILE PELVIC $53,638 8 payments
  9. IM NAILS $53,615 7 payments
  10. AUGMENT INJECTABLE $45,307 6 payments
  11. Other $389,246 259 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 30 billing codes

Paid by Medicare

$55,961

Medicare's payments for the services billed

Medicare patients

61

Average age 79

Services billed

79

31 women, 30 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 61%
Ischemic heart disease 39%
Diabetes 36%
Chronic kidney disease 36%
Osteoporosis 36%
Atrial fibrillation 33%
Depression 33%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

485 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Trauma in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record